These outcomes, along with a past report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like behavior in mice,two assist the principle of targeting ACKR3 as a novel technique to modulate the opioid process, which could open up new therapeutic avenues for opioid-linked Problems. Disclaimer: The above can be https://donaldr627hnr4.wikilima.com/user